Pioglitazone for type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, October 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy: 2 policy sources
twitter: 3 tweeters

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 272 Mendeley
citeulike: 1 CiteULike

Summary Policy documents Twitter Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

The selection and use of essential medicines: report of the WHO Expert Committee, 2013 (‎including the 18th WHO model list of essential medicines and the 4th WHO model list of essential medicines for children)‎

Cited by World Health Organization on 01 Jan 2014

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Pioglitazon (Actos) bij diabetes mellitus type 2

Cited by Zorginstituut Nederland on 22 Oct 2007

Zorginstituut Nederland (Netherlands Healthcare Institute) is an independent Dutch administrative body that ensures that Dutch citizens are and remain insured in accordance with the Health Insurance Act and the Long-Term Care Act. The Healthcare Institute occupies an independent position between the Ministry of Health, Welfare and Sport, health insurers, care providers and patient organizations.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.